InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,404.61
(
0.49%
)
Post# of 252301
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: genisi post# 148033

Friday, 08/31/2012 3:01:38 PM

Friday, August 31, 2012 3:01:38 PM

Post# of 252301
merck is starting a ph 2/3 1500 pt trial in MCI, so it will be ahead of lilly.

gantenerumab is furthest ahead as just switched its ph 2 in prodromal to a ph 3. I think will have a readout in 2015.

I would also put crenezumab ahead of lilly
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up